Dean Capital Management reduced its holdings in Maximus, Inc. (NYSE:MMS – Free Report) by 48.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 19,743 shares of the health services provider’s stock after selling 18,440 shares during the quarter. Dean Capital Management’s holdings in Maximus were worth $1,704,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also modified their holdings of the business. EP Wealth Advisors LLC acquired a new stake in Maximus during the fourth quarter worth about $329,000. Empowered Funds LLC boosted its stake in Maximus by 266.4% in the fourth quarter. Empowered Funds LLC now owns 9,544 shares of the health services provider’s stock valued at $824,000 after acquiring an additional 6,939 shares during the period. XTX Topco Ltd boosted its stake in Maximus by 95.0% in the fourth quarter. XTX Topco Ltd now owns 15,595 shares of the health services provider’s stock valued at $1,346,000 after acquiring an additional 7,599 shares during the period. Voloridge Investment Management LLC grew its holdings in shares of Maximus by 40.8% during the fourth quarter. Voloridge Investment Management LLC now owns 192,679 shares of the health services provider’s stock valued at $16,632,000 after purchasing an additional 55,872 shares during the last quarter. Finally, Oxford Asset Management LLP bought a new position in shares of Maximus during the fourth quarter valued at approximately $1,714,000. 97.21% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several analysts recently issued reports on the company. Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Finally, Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, Maximus has an average rating of “Hold”.
Maximus Trading Down 6.2%
Shares of NYSE:MMS opened at $55.72 on Friday. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. The company’s 50-day moving average price is $63.15 and its 200 day moving average price is $75.10. The company has a market cap of $2.93 billion, a PE ratio of 8.34 and a beta of 0.58. Maximus, Inc. has a fifty-two week low of $56.92 and a fifty-two week high of $100.00.
Maximus (NYSE:MMS – Get Free Report) last announced its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter in the previous year, the business earned $2.01 EPS. The firm’s revenue for the quarter was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. Sell-side analysts anticipate that Maximus, Inc. will post 8.43 earnings per share for the current year.
Maximus Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Friday, May 15th. Maximus’s payout ratio is currently 19.76%.
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Articles
- Five stocks we like better than Maximus
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
